⌘K

Login Start Free

Home/Filings/4/0001140361-14-013997

4//SEC Filing

PROVECTUS BIOPHARMACEUTICALS, INC. 4

Accession 0001140361-14-013997

$PVCTCIK 0000315545operating

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 5:17 PM ET

Size

14.6 KB

Accession

0001140361-14-013997

Insider Transaction Report

Form 4

Period: 2014-03-20

PROVECTUS BIOPHARMACEUTICALS, INC.PVCT

WACHTER ERIC PHD

DirectorVice President Pharmaceuticals

Transactions

Exercise/Conversion
Common Stock
2014-03-20$0.93/sh+600,000$558,000→ 6,032,484 total
Exercise/Conversion
Employee Stock Option (Right to buy)
2014-03-20−600,000→ 0 total
Exercise: $0.93From: 2011-09-06Exp: 2021-09-06→ Common Stock (600,000 underlying)
Exercise/Conversion
Common Stock
2014-03-20$0.75/sh+14,248$10,686→ 5,432,484 total
Exercise/Conversion
Employee Stock Option (Right to buy)
2014-03-20−25,000→ 0 total
Exercise: $0.95From: 2004-05-27Exp: 2014-05-27→ Common Stock (25,000 underlying)
Exercise/Conversion
Common Stock
2014-03-20$0.95/sh+25,000$23,750→ 5,418,236 total
Exercise/Conversion
Employee Stock Option (Right to buy)
2014-03-20−14,248→ 0 total
Exercise: $0.75From: 2005-05-25Exp: 2015-05-25→ Common Stock (14,248 underlying)

Holdings

Common Stock
(indirect: By Trust)
4,867

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

PROVECTUS BIOPHARMACEUTICALS, INC.

CIK 0000315545

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000315545

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 5:17 PM ET
Size: 14.6 KB

View on SEC.gov